Skip to main content
Premium Trial:

Request an Annual Quote

Canadian Gov't Grants Med BioGene $262K to Develop CVD Biomarkers

NEW YORK (GenomeWeb News) — Diagnostics developer Med BioGene has received a CA$307,000 ($262,000) grant from the Canadian government to develop biomarkers to help physicians detect and manage cardiovascular disease, the company said Friday.
 
The grant came from the National Research Council Canada Industrial Assistance Program.
 
MBI, based in Vancouver, BC, said it is working with CVD patient samples provided by the University of Ottawa Heart Institute to confirm its biomarkers.
 
Company President and CSO Nathan Yoganathan said he expects genetic biomarkers for CVD to be "an invaluable tool for periodic screening" for high-risk patients, or patients with early, mid-, or late-stage CVD.
 
Yoganathan said such a diagnostic would be a "first step" for cardiologists, who may then pursue more specific tests on patients found to be at risk. The test also could be used to prevent patients not at risk from undergoing “unnecessary and invasive testing," Yoganathan said.
 
MBI said it uses its gene expression-profiling system to develop and validate biomarkers for cardiovascular disease, lymphoma, and leukemia.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.